Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:KEQU NASDAQ:LAB NASDAQ:MASS NASDAQ:PRE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeKEQUKewaunee Scientific$35.98-0.1%$37.23$33.70▼$60.89$103.25M0.72,011 shs1,562 shsLABStandard BioTools$0.88-0.6%$0.98$0.79▼$1.72$345.94M1.393.45 million shs5.58 million shsMASS908 Devices$8.01+0.3%$7.40$5.03▼$9.34$302.13M0.63252,274 shs160,140 shsPREPrenetics Global$19.25-8.0%$18.17$6.88▼$23.63$353.17M0.24290,679 shs389,092 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceKEQUKewaunee Scientific-1.45%-11.22%-3.12%-12.10%-7.85%LABStandard BioTools+10.33%-23.60%-13.12%-8.96%-17.94%MASS908 Devices-1.36%-9.72%-2.20%+27.64%+14.47%PREPrenetics Global+4.65%-0.19%+29.52%+1.80%+171.11%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeKEQUKewaunee Scientific$35.98-0.1%$37.23$33.70▼$60.89$103.25M0.72,011 shs1,562 shsLABStandard BioTools$0.88-0.6%$0.98$0.79▼$1.72$345.94M1.393.45 million shs5.58 million shsMASS908 Devices$8.01+0.3%$7.40$5.03▼$9.34$302.13M0.63252,274 shs160,140 shsPREPrenetics Global$19.25-8.0%$18.17$6.88▼$23.63$353.17M0.24290,679 shs389,092 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceKEQUKewaunee Scientific-1.45%-11.22%-3.12%-12.10%-7.85%LABStandard BioTools+10.33%-23.60%-13.12%-8.96%-17.94%MASS908 Devices-1.36%-9.72%-2.20%+27.64%+14.47%PREPrenetics Global+4.65%-0.19%+29.52%+1.80%+171.11%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceKEQUKewaunee Scientific 2.00HoldN/AN/ALABStandard BioTools 1.67Reduce$1.3553.22% UpsideMASS908 Devices 2.00Hold$12.0049.81% UpsidePREPrenetics Global 2.50Moderate Buy$32.3367.97% UpsideCurrent Analyst Ratings BreakdownLatest KEQU, PRE, LAB, and MASS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/27/2026LABStandard BioTools Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D+) ➝ Sell (D)5/11/2026LABStandard BioTools Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Sell (D+)5/11/2026MASS908 Devices Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D-)4/24/2026LABStandard BioTools Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/21/2026PREPrenetics Global Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/13/2026MASS908 Devices Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D+) ➝ Hold (C-)4/2/2026KEQUKewaunee Scientific Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)3/16/2026PREPrenetics Global Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$29.00(Data available from 6/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookKEQUKewaunee Scientific$240.47M0.43$7.34 per share4.90$23.21 per share1.55LABStandard BioTools$85.33M4.03N/AN/A$1.10 per share0.80MASS908 Devices$56.20M5.39N/AN/A$3.97 per share2.02PREPrenetics Global$92.39M3.51N/AN/A$9.27 per share2.08Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateKEQUKewaunee Scientific$11.40M$3.729.67N/AN/A3.85%18.09%6.71%7/1/2026 (Estimated)LABStandard BioTools-$74.90M$0.204.41N/AN/A73.46%-8.18%-6.43%8/10/2026 (Estimated)MASS908 Devices$19.49M-$1.00N/AN/AN/A-62.40%-14.03%-10.40%8/4/2026 (Estimated)PREPrenetics Global-$37.71M-$4.02N/AN/AN/A-61.33%-19.61%-15.33%N/ALatest KEQU, PRE, LAB, and MASS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/10/2026Q1 2026 PreliminaryPREPrenetics Global-$0.49-$0.56-$0.07-$1.36N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthKEQUKewaunee ScientificN/AN/A-100.00%N/AN/ALABStandard BioToolsN/AN/AN/AN/AN/AMASS908 DevicesN/AN/AN/AN/AN/APREPrenetics GlobalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioKEQUKewaunee Scientific0.582.121.45LABStandard BioToolsN/A12.3611.92MASS908 DevicesN/A3.583.25PREPrenetics GlobalN/A2.972.72Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipKEQUKewaunee Scientific32.69%LABStandard BioTools53.74%MASS908 Devices88.06%PREPrenetics Global25.01%Insider OwnershipCompanyInsider OwnershipKEQUKewaunee Scientific13.30%LABStandard BioTools26.81%MASS908 Devices28.20%PREPrenetics Global7.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableKEQUKewaunee Scientific1,2392.87 million2.49 millionNot OptionableLABStandard BioTools620390.37 million285.71 millionOptionableMASS908 Devices6037.81 million27.15 millionOptionablePREPrenetics Global116.87 million15.56 millionNot OptionableKEQU, PRE, LAB, and MASS HeadlinesRecent News About These CompaniesPRE continues to post rapid growthJune 10 at 12:48 PM | msn.comPrenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring RevenueJune 10 at 8:30 AM | globenewswire.comMEXC SPACEX(PRE) Launchpad Subscriptions Exceed $173M Across Two PhasesJune 8 at 6:00 AM | globenewswire.comPrenetics Global (NASDAQ:PRE) Shares Down 0.2% - Should You Sell?June 5, 2026 | americanbankingnews.comPrenetics Adds DTC Pioneer Hudson Leogrande to Board as IM8 Scales Social Commerce PushJune 4, 2026 | tipranks.comPrenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta ExpansionJune 4, 2026 | globenewswire.comMEXC SPACEX(PRE) Phase 2 Launchpad: 30% Off Subscription and Extra Airdrops for Stock TradingJune 1, 2026 | globenewswire.comMEXC SPACEX(PRE) Launchpad Subscriptions Surpass $56 million, with the Offering Oversubscribed by Up to 15.5xMay 22, 2026 | globenewswire.comPrenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year PartnershipMay 20, 2026 | globenewswire.comPrenetics Global Ltd (PRE) Q1 2026 Earnings Call Highlights: Record Revenue Surge Amid ...May 15, 2026 | finance.yahoo.comPrenetics Global Q1 Earnings Call HighlightsMay 14, 2026 | marketbeat.comPrenetics Global Limited Class AMay 14, 2026 | edition.cnn.comPrenetics Lifts 2026 IM8 Revenue Outlook on Record Q1 Growth and Asset DivestitureMay 14, 2026 | tipranks.comPrenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8May 14, 2026 | globenewswire.comPrenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210MMay 14, 2026 | globenewswire.comPrenetics Global Limited to Announce Q1 2026 Financial Results on May 14, 2026May 8, 2026 | quiverquant.comQPrenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference CallMay 8, 2026 | globenewswire.comPrenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year PartnershipMay 7, 2026 | markets.businessinsider.comPrenetics' IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year PartnershipMay 7, 2026 | globenewswire.comPrenetics to Exit Bitcoin Holdings and Reinvest Up to $40 Million in Core IM8 Health BusinessMay 6, 2026 | theglobeandmail.comPrenetics Global Ltd.April 23, 2026 | barrons.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines3 Stocks to Own If Gas Prices Keep RisingBy Dan Schmidt | May 16, 2026Rocket Lab Is Down 24% From Its 52-Week High—Pullback or Problem?By Ryan Hasson | June 4, 2026The DRAM Shake-Up: Samsung Stumbles, Micron Chases $1000By Jeffrey Neal Johnson | May 12, 2026Will the SpaceX IPO Put These 5 Public Space Stocks Into a Higher Orbit?By Ryan Hasson | June 2, 2026Rocket Lab Just Hit a New All-Time High—Time to Buy or Let It Breathe?By Ryan Hasson | May 12, 2026KEQU, PRE, LAB, and MASS Company DescriptionsKewaunee Scientific NASDAQ:KEQU$35.98 -0.04 (-0.11%) Closing price 04:00 PM EasternExtended Trading$35.61 -0.37 (-1.03%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.Standard BioTools NASDAQ:LAB$0.88 -0.01 (-0.58%) Closing price 04:00 PM EasternExtended Trading$0.89 +0.01 (+1.01%) As of 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.908 Devices NASDAQ:MASS$8.01 +0.02 (+0.25%) Closing price 04:00 PM EasternExtended Trading$8.02 +0.01 (+0.12%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.Prenetics Global NASDAQ:PRE$19.25 -1.68 (-8.03%) Closing price 04:00 PM EasternExtended Trading$19.18 -0.07 (-0.34%) As of 05:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Biggest Opportunity From SpaceX’s IPO May Surprise You Chewy’s Growth Engine Is Stronger Than the Market Thinks Everpure: AI Storage Uncertainty Overshadows Breakneck Growth This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason FuelCell Energy Just Got a Wake-Up Call From Wall Street Intel Is the Market's Most Mispriced AI Hedge Palantir's AIPCon Shows Why Customers Are Fueling the Bull Case Uranium Energy Corp Melts Down—Nuclear Opportunity at Hand Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
